Sun Pharmaceutical Carbamazepine 200mg tablets recalled for manufacturing defect
Sun Pharmaceutical's Carbamazepine 200mg tablets (Lot #AD94033, expiring 5/31/2028) contain black spots caused by burnt ingredients during manufacturing. The tablets do not meet quality standards, though no injuries have been reported.
From the FDA notice · Read the official notice ↗ · All Sun Pharmaceutical recalls
What to do
- Check if you have Carbamazepine tablets from Lot #AD94033 (expiring 5/31/2028).
- Do not stop taking your medication without talking to your doctor or pharmacist first.
- Contact your pharmacy or doctor for a replacement or alternative.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Carbamazepine Tablets, USP, 200mg, 1000 count bottles, Rx only, Manufactured by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Distributed by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC 51672-4005-3.
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
Details
- Units affected
- 1968 Bottles (1000Tablets/Bottle)
- Illnesses reported
- None reported
- Manufactured in
- 2 Independence Way, Princeton, NJ, United States
- Classification
- Class II
- Recall number
- D-0770-2026
In the FDA's words
- Description
- Carbamazepine Tablets, USP, 200mg, 1000 count bottles, Rx only, Manufactured by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Distributed by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC 51672-4005-3. CGMP Deviations; black spots found on tablets from burnt excipient during manufacturing Lot # AD94033, Exp Date: 5/31/2028. Distribution: US Nationwide. Affected quantity: 1968 Bottles (1000Tablets/Bottle)
- Hazard
- CGMP Deviations; black spots found on tablets from burnt excipient during manufacturing
More from Sun Pharmaceutical
See all- Sun Pharma sumatriptan-naproxen tablets recalled, failed dissolution
ModerateFDANov 18, 2026
- Sun Pharmaceutical lisdexamfetamine recalled for failed dissolution
ModerateFDANov 6, 2026
- Taro Tretinoin Cream 0.05% recalled for failed impurity specifications
ModerateFDAOct 14, 2026
- Sun nystatin cream recalled for failed stability specifications
ModerateFDASep 23, 2026